Ilypsa, Inc. is a privately held biopharmaceutical company discovering and developing a pipeline of next-generation renal care pharmaceutical products. Pioneeri...
| Website | http://www.ilypsa.com |
| Revenue | $7.4 million |
| Employees | View employees |
| Founded | 2002 |
| Address | 3406 Central Expy, Santa Clara, California 95051, US |
| Phone | +1 408-215-2800 |
| Industry | Pharmaceuticals, Biotechnology, Drug Discovery, Healthcare, Science and Engineering, Manufacturing, Drug Manufacturing & Research, Medical, Health Care |
| Competitors | Amgen, Roche, Bristol Myers Squibb, AbbVie, Pfizer, Novartis, Gilead Sciences, Sanofi, Merck & Co., Inc., Johnson & Johnson +36 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Ilypsa , Inc. employee's phone or email?
Ilypsa , Inc. Questions
The Ilypsa , Inc. annual revenue was $7.4 million in 2026.
Ilypsa , Inc. is based in Santa Clara, California.
The NAICS codes for Ilypsa , Inc. are [32, 32541, 3254, 325].
The SIC codes for Ilypsa , Inc. are [283, 2834, 28].
G2Crowd Trusted
300K+
Plugin Users
